SHANNON GREENQUIST: Open Payments
NPI 1174062368 · KANKAKEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,134 in 100 payments from 17 companies in 2025. Trend: 2023 $1,760 · 2024 $1,484 · 2025 $2,134
Food & beverage: $2,134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $466 |
| Merck Sharp & Dohme LLC | 11 | $230 |
| Novartis Pharmaceuticals Corporation | 8 | $192 |
| PFIZER INC. | 9 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $167 |
| Actelion Pharmaceuticals US, Inc. | 7 | $155 |
| BridgeBio Pharma, Inc. | 4 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Amgen Inc. | 6 | $98 |
| Abbott Laboratories | 5 | $94 |
Products named: FARXIGA, LEQVIO, WAINUA, JARDIANCE, VERQUVO, VYNDAQEL, Attruby, REPATHA.
Industry payments across IL — which companies pay providers there.
